Positron Emission Tomography in Lung Cancer

Slides:



Advertisements
Similar presentations
Fig. 2. Arterial fluorodeoxyglucose (FDG) uptake related to atherosclerosis. On positron emission tomography (PET) coronal (A), PET/CT fusion coronal (B),
Advertisements

CT and PET imaging in non-small cell lung cancer
Stage IV non–small cell lung cancer (NSCLC)
Jeffrey Bradley, MD  Journal of Thoracic Oncology 
Standard Report Terms for Chest Computed Tomography Reports of Anterior Mediastinal Masses Suspicious for Thymoma  Edith M. Marom, MD, Melissa L. Rosado-de-Christenson,
Fig FDG PET-CT and diagnostic contrast-enhanced chest CT in patient with angioimmunoblastic T-cell lymphoma. MIP image (A) demonstrates intense 18FDG.
PET, CT, and MRI with Combidex for mediastinal staging in non-small cell lung carcinoma  Kemp H Kernstine, MD, PhD, William Stanford, MD, Brian F Mullan,
FDG PET-CT Aids in the Preoperative Assessment of Patients with Newly Diagnosed Thymic Epithelial Malignancies  Marcelo F.K. Benveniste, MD, Cesar A.
Pulmonary Lobectomy in a Patient With a Left Ventricular Assist Device
PET/CT Fusion Scan in Lung Cancer: Current Recommendations and Innovations  Cristina Gámez, MD, PhD, Rafael Rosell, MD, PhD, Alejandro Fernández, MD, PhD,
[18F] 3-deoxy-3′-fluorothymidine positron emission tomography: alternative or diagnostic adjunct to 2-[18f]-fluoro-2-deoxy-d-glucose positron emission.
Preoperative Localization of Lung Nodules With Fiducial Markers: Feasibility and Technical Considerations  Amita Sharma, MD, Shaunagh McDermott, MD, Douglas.
Mediastinal lymph node staging of non-small-cell lung cancer: A prospective comparison of computed tomography and positron emission tomography  Walter.
Hiren J. Mehta, MD, Tan-Lucien Mohammed, MD, Michael A. Jantz, MD 
Paraneoplastic Opsoclonus-Myoclonus Syndrome as a New and Single Manifestation of Relapsing Disease in a Patient with Small Cell Lung Cancer  Ernest Nadal,
Detection of extrathoracic metastases by positron emission tomography in lung cancer  Walter Weder, MD, Ralph A Schmid, MD, Helke Bruchhaus, MD, Sven Hillinger,
The Case of the Missed Chest Radiograph: Bilateral Mammary Gland Metastases Mimicking Multifocal Primary Breast Cancer as the Initial Manifestation of.
A 40-Year-Old Man With a Nodular Lung Disease and Skin Rash
Andranik Petrosyan, MD, Patrice Bergeron, MD 
Renee Sunday, MD, Lary A Robinson, MD, Voytek Bosek, MD 
Sarcoid-Like Reaction Mimics Progression of Disease After Induction Chemotherapy for Lung Cancer  Masayuki Chida, MD, PhD, Takashi Inoue, MD, Koichi Honma,
Resection of Mucinous Lung Adenocarcinoma Presenting with Intractable Bronchorrhea  Motoshi Takao, MD, PhD, Takehiro Takagi, MD, Hitoshi Suzuki, MD, PhD,
Salvage Lung Resection After Definitive Radiation (>59 Gy) for Non-Small Cell Lung Cancer: Surgical and Oncologic Outcomes  Julie E. Bauman, MD, Michael.
Unexpected Small Bowel Intussusception Caused by Lung Cancer Metastasis on 18F- Fluorodeoxyglucose PET-CT  Jeong Won Lee, MD, Seok-Ki Kim, MD, Ji Won Park,
Metachronous Germ Cell Tumors of the Mediastinum
Misdiagnosis of a Small Cell Lung Cancer Resulting From Inaccurate Pathology  Tie-niu Song, MD, Jian-hua Zhang, MD, PhD, Bin Li, PhD, Hui Zhou, BA, Peng.
Meta-Analysis of Positron Emission Tomographic and Computed Tomographic Imaging in Detecting Mediastinal Lymph Node Metastases in Nonsmall Cell Lung Cancer 
Positron emission tomographic imaging with fluorodeoxyglucose is efficacious in evaluating malignant pulmonary disease  Geoffrey M. Graeber, MD*, Naresh.
Artificial Pneumothorax With Position Adjustment for Computed Tomography-Guided Percutaneous Core Biopsy of Mediastinum Lesions  Zheng-Yu Lin, MD, Yin-Guan.
Extramedullary hematopoiesis mimicking metastatic lung carcinoma
Successful Crizotinib Retreatment after Crizotinib-Induced Interstitial Lung Disease  Satoru Yanagisawa, MD, PhD, Akira Inoue, MD, PhD, Akira Koarai, MD,
Small Cell Lung Cancer in a 26-Year-Old Man with Significant Cannabis Exposure  Suzanne Graef, MB, ChB, Chuan Gee Choo, MB, ChB, Adrian Warfield, MB, ChB,
Nikolaas De Maeyer, MD, Walter De Wever, MD, PhD, Christophe M
Thyroid lung metastasis diagnosed 47 years after thyroidectomy1
The radiologic appearance of intercostal muscle flap
Salvage Operation in Case of Oligometastatic Disease
Sarah Cullivan, MD, Karen Redmond, MD, Carole Ridge, MD, Oisin J
Christopher K. Mehta, MD, Colin T
The role of positron emission tomography for non-small cell lung cancer  Albert J. Chang, MD, PhD, Farrokh Dehdashti, MD, Jeffrey D. Bradley, MD  Practical.
Metachronous Lung Cancer After Pleurectomy/Decortication
Salvage Operation for Late Recurrence After Stereotactic Body Radiotherapy for Lung Cancer: Two Patients With No Viable Cancer Cells  Naohiro Taira, MD,
Steve R. Siegal, MD, John G. Hunter, MD, James P. Dolan, MD, MCR 
The Role of Surgery in the Management of Primary Thymic Mucosa-associated Lymphoid Tissue (MALT) Lymphoma  Kimihiro Shimizu, MD, PhD, Izumi Takeyoshi,
Lawek Berzenji, BM, Paul E
Pulmonary Metastases from Cervical Adenocarcinoma Regress to a ‘Hole’ Lot of Nothing  Michael Guandalini, MBBS (Hons), BPhty, Karin Steinke, MD, MS, PD,
Matthew Reichert, MD, Eric S. Bensadoun, MD 
Jeffrey Bradley, MD  Journal of Thoracic Oncology 
Multiple Pulmonary Nodules in an Elderly Woman
Nicholas W. Choong, MD, Robert S. Hellman, MD 
Extensive Invasion of the Left Atrium by Lung Cancer
Antiangiogenesis Induced Tumor Cavitation in Lung Cancer
Intrapulmonary lymph nodes enlarged after lobectomy for lung cancer
Sclerosing hemangioma with metastases to multiple nodal stations
Can FDG-PET reduce the need for mediastinoscopy in potentially resectable nonsmall cell lung cancer?  Kemp H Kernstine, MD, PhD, Kelley A McLaughlin,
Primary desmoid tumor of the posterior mediastinum
Synchronous primary lung carcinoma and lung metastasis from extrathoracic carcinoma  Shinji Kanemitsu, MD, Motoshi Takao, MD, PhD, Akira Shimamoto, MD,
Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the staging of lung cancer  Catherine A.B Saunders, Julian.
John E Langenfeld, MD  The Annals of Thoracic Surgery 
Neal S Goldstein, MD  The Annals of Thoracic Surgery 
Clinical-pathologic conference in general thoracic surgery: Malignant transformation of recurrent respiratory papillomatosis  Benjamin D. Kozower, MD,
Prognostic Role of Positron Emission Tomography and High-Resolution Computed Tomography in Clinical Stage IA Lung Adenocarcinoma  Hirofumi Uehara, MD,
A and B, Computed tomography (CT) of the chest prior to cabozantinib therapy demonstrated a dominant mass in the left upper lobe (B, black arrow), measuring.
Pulmonary infarct cytologically mimicking adenocarcinoma of the lung
FDG imaging of a pulmonary artery sarcoma
Lack of FDG Uptake in Small Cell Carcinoma Associated with ANNA-1 Positive Paraneoplastic Autonomic Neuropathy  Matthew S. Block, MD, PhD, Robert Vassallo,
Resection of primary brachial plexus tumor using a modified Dartevelle anterior approach  Andrew Morton, Mark J Krasna, MD, Charles S White, MD, Joseph.
Awais Ashfaq, MD, Holenarasipur R. Vikram, MD, Janis E
Patterns-of-Care for Thoracic Stereotactic Body Radiotherapy among Practicing Radiation Oncologists in the United States  Megan E. Daly, MD, Julian R.
Thoracic Lymphangiomatosis: Report of 3 Patients With Different Presentations  Yanguo Liu, MD, Xizhao Sui, MD, Kezhong Chen, MD, Jianfeng Li, MD, Fan Yang,
Evaluation of lymph node metastases in squamous cell carcinoma of the esophagus with positron emission tomography  Kwhanmien Kim, MD, Seung Joon Park,
Presentation transcript:

Positron Emission Tomography in Lung Cancer Val J Lowe, MD, Keith S Naunheim, MD  The Annals of Thoracic Surgery  Volume 65, Issue 6, Pages 1821-1829 (June 1998) DOI: 10.1016/S0003-4975(98)00106-4

Fig 1 Glucose and [18F]fluorodeoxyglucose (18FDG) are transported into the cell in a similar fashion. After FDG phosphorylation, FDG-6-PO4 does not proceed down cellular metabolic pathways, and only minimal amounts leave the cell. The Annals of Thoracic Surgery 1998 65, 1821-1829DOI: (10.1016/S0003-4975(98)00106-4)

Fig 2 (A) Pulmonary nodule (broken arrow) in left anterior lung on computed tomography is hypermetabolic on (B) [18F]fluorodeoxyglucose positron emission tomography (solid arrow). A biopsy sample from the nodule was positive for adenocarcinoma. The Annals of Thoracic Surgery 1998 65, 1821-1829DOI: (10.1016/S0003-4975(98)00106-4)

Fig 3 (A) A 53-year-old man had a large left lung mass (large cell undifferentiated tumor) with associated left hilar adenopathy (arrow) on computed tomography. (B) It also demonstrated a 1.8-cm nonspecific left adrenal mass (arrow). (C) Coronal positron emission tomography showed hypermetabolism indicative of tumor in the left lung mass and left hilar nodes as well as right tracheobronchial nodal (broken arrow), left pleural, and left adrenal (solid arrow) disease. Right-sided adrenal disease is also likely present as seen on position emission tomography, although the right adrenal gland was not enlarged on computed tomography. The Annals of Thoracic Surgery 1998 65, 1821-1829DOI: (10.1016/S0003-4975(98)00106-4)

Fig 4 A 52-year-old man had a history of right upper lobe lung cancer. (A) The chest radiograph showed an ill-defined right hilar opacity and right paratracheal fullness. (B) Coronal positron emission tomography demonstrated right hilar (arrow) and right paratracheal hypermetabolism indicative of recurrent tumor. The Annals of Thoracic Surgery 1998 65, 1821-1829DOI: (10.1016/S0003-4975(98)00106-4)

Fig 5 Transaxial 18F-fluorodeoxyglucose positron emission tomography (PET) image from patient with a history of left lung cancer seen with a new left pleural effusion demonstrating multiple focal areas of hypermetabolism involving the left pleural surface (arrow). The PET metabolic image (bright white) is superimposed on a PET soft-tissue density image or attenuation scan (seen as light gray), also routinely obtained for PET imaging, that shows increased density (pleural fluid) in left lung region. The biopsy specimen documented recurrent tumor in this pleural region. The Annals of Thoracic Surgery 1998 65, 1821-1829DOI: (10.1016/S0003-4975(98)00106-4)